Drug approvals

FILE - In this Tuesday, May 13, 2014 file photo, AstraZeneca CEO Pascal Soriot leaves the British Parliament's Business Innovation and Skills Committee after a hearing in central London. Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO Pascal Soriot and Paul Stoffels, chief scientific officer of Johnson & Johnson, said Thursday Sept. 24, 2020, that they recognize the coronavirus emergency demands increased transparency from vaccine developers to ensure the public has faith in the end product. (AP Photo/Lefteris Pitarakis, File)
September 24, 2020 - 7:32 am
LONDON (AP) — Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO...
Read More
Dr. Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), testifies during a House Subcommittee hearing on the Coronavirus crisis, Friday, July 31, 2020 on Capitol Hill in Washington. (Kevin Dietsch/Pool via AP)
September 02, 2020 - 6:08 pm
PROVIDENCE, R.I. (AP) — The federal government has told states to prepare for a coronavirus vaccine to be ready to distribute by Nov. 1. The timeline raised concern among public health experts about an “October surprise" — a vaccine approval driven by political considerations ahead of a...
Read More
People wearing face masks to help protect against the spread of the coronavirus pray while maintaining social distancing during a service at the Chogyesa temple in Seoul, South Korea, Sunday, Aug. 23, 2020. (AP Photo/Ahn Young-joon)
August 23, 2020 - 9:55 pm
SEOUL, South Korea — South Korea counted its 11th straight day of triple-digit daily jumps in coronavirus cases as officials tighten social distancing restrictions nationwide to combat what they describe as the biggest crisis since the emergence of COVID-19. The 266 cases reported by the Korea...
Read More
FILE - This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Investors are driving shares of drug developer BioMarin down by a third after U.S. regulators rejected its potentially game-changing gene therapy for hemophilia A patients. The FDA's rejection late Tuesday, Aug. 18, 2020, means BioMarin will have to complete an ongoing late-stage patient study. (AP Photo/Jacquelyn Martin, File)
August 19, 2020 - 3:07 pm
FAIRLESS HILLS, PA (AP) — Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime treatment. The U.S...
Read More
President Donald Trump speaks at a news conference in the James Brady Press Briefing Room at the White House, Thursday, Aug. 13, 2020, in Washington. (AP Photo/Andrew Harnik)
August 18, 2020 - 4:47 pm
ISLAMABAD — Pakistan’s drug regulatory agency has approved final-phase testing of a Chinese-made vaccine against coronavirus in this Islamic nation where the new virus has caused 617 deaths since February. In Monday’s statement, the state-run National Institute of Health said the approval to carry...
Read More
In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russian President Vladimir Putin's announcement that his country is the first to approve a coronavirus vaccine hasn't provoked the awe and wonder of the Soviet Union’s launch of the first satellite into orbit in 1957. Instead the announcement was met by doubts about the science and safety of the vaccine. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP)
August 12, 2020 - 2:38 pm
WASHINGTON (AP) — No, Russia isn't having a Sputnik moment. The announcement Tuesday by Russian President Vladimir Putin that his country was the first to approve a coronavirus vaccine did not provoke the awe and wonder of the Soviet Union’s launch of the first satellite into orbit in 1957. Instead...
Read More
File- This Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Richard Drew, File)
July 22, 2020 - 5:40 pm
WASHINGTON (AP) — The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, Health and Human Services Secretary Alex Azar announced Wednesday. The U.S. could buy another 500 million doses...
Read More
Orange Man, Brian McKee, delivers care packages to individuals who are isolating, to celebrate the 12th of July as traditional large-scale parades were cancelled this year due to the pandemic, in east Belfast, Monday, July 13, 2020. The Twelfth is being celebrated on 13 July as 12 July this year fell on a Sunday, to mark the anniversary of the victory of Protestant William of Orange over Catholic King James II at the Battle of the Boyne in July 1690. (Niall Carson/PA via AP)
July 13, 2020 - 1:28 pm
The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments Monday related to the national and global response, the work place and the spread of the virus. ________________________ FRONT LINE VIRUS COMPANIES: — Two vaccine candidates...
Read More
FILE - In this May 14, 2020, file pool photo Rick Bright, former director of the Biomedical Advanced Research and Development Authority, testifies before a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus outbreak on Capitol Hill in Washington. Bright, a government whistleblower ousted from a leading role in battling COVID-19, alleged Thursday, June 25, that the Trump administration has intensified its campaign to punish him for revealing shortcomings in the U.S. response. (Shawn Thew/Pool via AP, File)
June 25, 2020 - 5:41 pm
WASHINGTON (AP) — A government whistleblower ousted from a leading role in battling COVID-19 alleged Thursday that the Trump administration has intensified its campaign to punish him for revealing shortcomings in the U.S. response. Dr. Rick Bright, former director of the Biomedical Advanced...
Read More
FILE - In this Aug. 2, 2018, file photo, the U.S. Food and Drug Administration (FDA) building is visible behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday, June 15, 2020, the game built by Boston-based Akili Interactive Labs can improve attention function. (AP Photo/Jacquelyn Martin, File)
June 15, 2020 - 7:17 pm
BOSTON (AP) — The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx,...
Read More

Pages